Article
BRCA1: mechanisms of inactivation and implications for management of patients.
Lancet (London, England) - 28 Sept 2002
Kennedy Richard D, Quinn Jennifer E, Johnston Patrick G, Harkin D Paul
Abstract excerpt
The BRCA1 gene was cloned in 1994 as one of the genes that conferred genetic predisposition to early-onset breast and ovarian cancer. Since then, a genetic test for identification of high-risk individuals has been developed. Despite being implicated in many important cellular pathways, including DNA repair and regulation of transcription, the exact mechanism by which inactivation of BRCA1 might lead to malignant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
